Cross-institution positioning
Mar 27, 2026Reduction leaning. 2 accumulating, 1 reducing, 1 exited across 4 comparable institutions.
Source: Schedule 13 researchNHC Institutional Ownership
NATIONAL HEALTHCARE CORP
Latest stored close $227.11 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
45/100
4 tracked · 4 comparable
Latest filing
Mar 27, 2026
Positive breadth
2 positive · 2 negative
Recent close
$227.11
Research confidence
Medium
Institutional Research 36/100 · 2 accumulating · 2 reducing / exited
Ownership history
Reported ownership % history
Latest filing Mar 27, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating2
Newly reported0
Reducing / exited
2
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 45/100
Confidence:Medium
Why this signal
- 2 tracked institutions accumulating versus 2 reducing/exited.
- 1 tracked institution shows persistent accumulation.
- 1 tracked institution show accelerating accumulation.
- Latest comparable Form 13F activity is net positive across tracked managers.
Institutional
47/100
Insiders
22/100
Fundamentals
59/100
Events
50/100
Quarterly 13F activity
Jun 30, 20262 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 22, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 15 sales by 6 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Aug 11, 20262 non-amendment material events in the last 90 days; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 6, 2026Revenue +8.8% YoY; Net income +70.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 90% through its reported 52-week range; +95.1% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Vanguard Group.
Filed Mar 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Mar 27, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Morgan Stanley
Filed Mar 12, 2026
Direction locked
Dimensional Fund Advisors
Filed Feb 9, 2024
Direction locked
BlackRock
Filed Jan 8, 2024
Direction locked
BlackRock
Filed Oct 17, 2025
Direction locked
Vanguard Group
Filed Mar 27, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Morgan Stanley
Filed Mar 12, 2026
Dimensional Fund Advisors
Filed Feb 9, 2024
BlackRock
Filed Jan 8, 2024
BlackRock
Filed Oct 17, 2025
Vanguard Group
Filed Mar 27, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales95 reporting owner(s)
90-day purchase breadth0
90-day sale breadth6Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Dodson Vicki L | SOpen-market or private sale | Shares of Common Stock held in my name | 4.8K | $225.00 | Direct | Sep 23, 2026 |
| Sep 11, 2026 | KIDD BRIAN F | SOpen-market or private sale | Common Stock | 6.8K | $225.70 | Direct | Sep 14, 2026 |
| Sep 10, 2026 | McCreary Josh A | SOpen-market or private sale | Common Stock | 68 | $225.59 | Direct | Sep 14, 2026 |
| Sep 10, 2026 | McCreary Josh A | SOpen-market or private sale | Common Stock | 1.3K | $225.09 | Direct | Sep 14, 2026 |
| Sep 10, 2026 | McCreary Josh A | SOpen-market or private sale | Common Stock | 789 | $223.78 | Direct | Sep 14, 2026 |
| Sep 10, 2026 | McCreary Josh A | SOpen-market or private sale | Common Stock | 571 | $222.73 | Direct | Sep 14, 2026 |
| Aug 28, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $222.50 | Direct | Sep 2, 2026 |
| Aug 25, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $227.00 | Direct | Sep 2, 2026 |
| Aug 25, 2026 | Gifford David R. | SOpen-market or private sale | Common Stock | 1.8K | $225.42 | Direct | Aug 28, 2026 |
| Aug 20, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $237.00 | Direct | Sep 2, 2026 |
| Aug 20, 2026 | Gifford David R. | MExercise or conversion of derivative · derivative | Option to Purchase Common Stock [2026 Grant] | 6.5K | $0.00 | Direct | Aug 21, 2026 |
| Aug 20, 2026 | Gifford David R. | AGrant, award, or other acquisition | Common Stock | 4.7K | $236.75 | Direct | Aug 21, 2026 |
| Aug 20, 2026 | Gifford David R. | MExercise or conversion of derivative | Common Stock | 6.5K | $171.42 | Direct | Aug 21, 2026 |
| Aug 19, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $237.18 | Direct | Sep 2, 2026 |
| Aug 19, 2026 | Flatt Stephen Fowler | SOpen-market or private sale | Common Stock | 1.5K | $237.08 | Direct | Aug 20, 2026 |
| Aug 17, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $226.00 | Direct | Sep 2, 2026 |
| Aug 14, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $222.11 | Direct | Sep 2, 2026 |
| Aug 13, 2026 | Gifford David R. | MExercise or conversion of derivative · derivative | Option to Purchase Common Stock [2026 Grant] | 1.0K | $0.00 | Direct | Aug 17, 2026 |
| Aug 13, 2026 | Gifford David R. | MExercise or conversion of derivative | Common Stock | 1.0K | $171.42 | Direct | Aug 17, 2026 |
| Aug 12, 2026 | FLATT BEN ANDERSON SR | SOpen-market or private sale | Common Stock | 1.0K | $221.21 | Direct | Sep 2, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events0
90-day capital-related0
90-day equity-related0
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 11, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 11, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 1, 2026 | 8-K | 1.01, 1.02, 2.01, 2.03, 7.01, 9.01 | Material definitive agreement; Termination of material agreement; Acquisition or disposition of assets; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
| May 27, 2026 | 8-K | 1.01, 1.02, 2.03, 9.01 | Material definitive agreement; Termination of material agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| May 15, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| May 13, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 8, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 7, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Apr 22, 2026 | 8-K | 1.01, 1.02, 7.01, 9.01 | Material definitive agreement; Termination of material agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Feb 27, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Feb 17, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Feb 13, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$408.0M
Q2 2026
+8.8% YoY 10-Q filed Aug 6, 2026
Operating income
$48.9M
Q2 2026
+43.5% YoY 10-Q filed Aug 6, 2026
Operating margin
12.0%
Q2 2026
+2.9 pts YoY 10-Q filed Aug 6, 2026
Net income
$40.3M
Q2 2026
+70.0% YoY 10-Q filed Aug 6, 2026
Diluted EPS
$2.54
Q2 2026
+67.1% YoY 10-Q filed Aug 6, 2026
Operating cash flow
$105.8M
YTD through Jun 30, 2026
+3.7% YoY 10-Q filed Aug 6, 2026
Free cash flow
$83.6M
YTD through Jun 30, 2026
-2.4% YoY 10-Q filed Aug 6, 2026
Cash & equivalents
$39.2M
As of Jun 30, 2026
-64.7% YoY 10-Q filed Aug 6, 2026
Long-term debt
$0
As of Jun 30, 2026
-100.0% YoY 10-Q filed Aug 6, 2026
Assets
$1.5B
As of Jun 30, 2026
-1.6% YoY 10-Q filed Aug 6, 2026
Liabilities
$408.9M
As of Jun 30, 2026
-23.8% YoY 10-Q filed Aug 6, 2026
Stockholders’ equity
$1.1B
As of Jun 30, 2026
+9.8% YoY 10-Q filed Aug 6, 2026
Shares outstanding
15.7M
As of Aug 3, 2026
+1.0% YoY 10-Q filed Aug 6, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $408.0M | +8.8% |
| Ended Mar 31, 2026 | $381.8M | +2.2% |
| Ended Sep 30, 2025 | $382.7M | +12.5% |
| Ended Jun 30, 2025 | $374.9M | +24.7% |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $1.5B | +16.1% |
| Ended Dec 31, 2024 | $1.3B | +14.5% |
| Ended Dec 31, 2023 | $1.1B | +5.1% |
| Ended Dec 31, 2022 | $1.1B | +1.1% |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$226.61
View live quote ↗
52-week low
$114.59
Sep 16, 2025
52-week high
$239.29
Aug 20, 2026
Below 52-week high
5.3%
1W return
+2.6%
1M return
+1.4%
3M return
+15.9%
6M return
+40.4%
YTD return
+65.3%
1Y return
+95.1%
30-day volatility
37.0%
90-day volatility
35.8%
1Y max drawdown
-10.1%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 21 filing(s) · 18 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Exit below reporting threshold | 0 -1.4M | 0.00% -9.19 pts | $161.44 | $161.03 | $227.11 |
| Morgan Stanley CIK0000895421 | Dec 31, 2025 observed Mar 12, 2026 filed · 70d Schedule 13G amendment | Reported accumulation | 1.1M +248.6K | 7.10% +1.60 pts | $137.09 | $155.88 | $227.11 |
| BlackRock CIK0002012383 | Sep 30, 2025 observed Oct 17, 2025 filed · 17d Schedule 13G amendment | Reported reduction | 1.8M -179.1K | 12.00% -0.80 pts | $121.51 | $121.95 | $227.11 |
Explore more institutional activity
Related research
Compare NHC with other securities showing similar institutional activity or recent accumulation across several tracked institutions.